BCG VACCINE
Biological
Merck Sharp & Dohme LLC
Total Payments
$102,098
Transactions
1
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $102,098 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $102,098 | 1 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| STUDY NAME#A Phase I single site open label clinical trial for the development of a human BCG challenge model to assess TB drugs and vaccines | Merck Sharp & Dohme LLC | $102,098 | 0 |
Top Doctors Receiving Payments for BCG VACCINE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Seattle, WA | $102,098 | 1 |
Ad
Manufacturing Companies
- Merck Sharp & Dohme LLC $102,098
Product Information
- Type Biological
- Total Payments $102,098
- Total Doctors 0
- Transactions 1
About BCG VACCINE
BCG VACCINE is a biological associated with $102,098 in payments to 0 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is Merck Sharp & Dohme LLC.
Payment data is available from 2024 to 2024. In 2024, $102,098 was paid across 1 transactions to 0 doctors.
The most common payment nature for BCG VACCINE is "Unspecified" ($102,098, 100.0% of total).
BCG VACCINE is associated with 1 research study, including "STUDY NAME#A Phase I single site open label clinical trial for the development of a human BCG challenge model to assess TB drugs and vaccines" ($102,098).